11 - 13 out of 13Page size: 10
  1. 2018

  2. Conventional anti-glioblastoma chemotherapy affects proteoglycan composition of brain extracellular matrix in rat experimental model in vivo

    Tsidulko, A. Y., Bezier, C., De La Bourdonnaye, G., Suhovskih, A. V., Pankova, T. M., Kazanskaya, G. M., Aidagulova, S. V. & Grigorieva, E. V., 2 Oct 2018, In: Frontiers in Pharmacology. 9, OCT, p. 1104 13 p., 1104.

    Research output: Contribution to journal › Article › peer-review

  3. Heparan sulfate accumulation and perlecan/HSPG2 up-regulation in tumour tissue predict low relapse-free survival for patients with glioblastoma

    Kazanskaya, G. M., Tsidulko, A. Y., Volkov, A. M., Kiselev, R. S., Suhovskih, A. V., Kobozev, V. V., Gaytan, A. S., Aidagulova, S. V., Krivoshapkin, A. L. & Grigorieva, E. V., 1 Mar 2018, In: Histochemistry and Cell Biology. 149, 3, p. 235-244 10 p.

    Research output: Contribution to journal › Article › peer-review

  4. 2017

  5. Heparan sulfate biosynthetic system is inhibited in human glioma due to EXT1/2 and HS6ST1/2 down-regulation

    Ushakov, V. S., Tsidulko, A. Y., De La Bourdonnaye, G., Kazanskaya, G. M., Volkov, A. M., Kiselev, R. S., Kobozev, V. V., Kostromskaya, D. V., Gaytan, A. S., Krivoshapkin, A. L., Aidagulova, S. V. & Grigorieva, E. V., 1 Nov 2017, In: International Journal of Molecular Sciences. 18, 11, 11 p., 2301.

    Research output: Contribution to journal › Article › peer-review

Previous 1 2 Next

ID: 3457097